• <em>Bifidobacterium longum</em> K5 Prevents Enterohaemorrhagic <em>Escherichia coli</em> O157:H7 Infection in Mice through the Modulation of the Gut Microbiota
• <em>In situ</em> deposition of nanobodies by an engineered commensal microbe promotes survival in a mouse model of enterohemorrhagic <em>E. coli</em>
• "Eculizumab First" in the Management of Posttransplant Thrombotic Microangiopathy
• A 26-year-old man with multiple organ failure caused by <em>Aeromonas dhakensis</em> infection: a case report and literature review
• A better future for children with STEC-hemolytic uremic syndrome: news from Argentina
• A challenging STEC strain isolation from patients' stools: an O166:H15 STEC strain with the <em>stx2</em> gene
• A Copernican revolution of multigenic analysis: A retrospective study on clinical exome sequencing in unclear genetic disorders
• A pediatric case with hemolytic uremic syndrome associated with COVID-19, which progressed to end-stage kidney disease
• A Rare Case of Atypical Hemolytic Uremic Syndrome (aHUS) Precipitated by Dengue and the Treatment Landscape in Singapore
• A Rare Case of Atypical Hemolytic Uremic Syndrome (HUS) in an Adult Male: A Catastrophic Presentation
• A Severe Form of Atypical Hemolytic Uremic Syndrome in a Two-Year-Old Girl: A Case Report
• A Worrying and Puzzling Case of Hypertension Presenting to the Emergency Department
• Acquired Thrombotic Thrombocytopenic Purpura (TTP) Presenting With Synthetic Cannabinoid Use
• Adolescence-onset atypical hemolytic uremic syndrome: is it different from infant-onset?
• An Atypical Case of Hemolytic Uremic Syndrome Caused by Shiga Toxin Produced by Aeromonas spp
• An expert discussion on the atypical hemolytic uremic syndrome nomenclature-identifying a road map to precision: a report of a National Kidney Foundation Working Group
• An unusual case of adult-onset still's disease complicated with anti-complement factor H antibodies associated atypical haemolytic uraemic syndrome
• ANCA-Associated Vasculitis with Systemic Thrombotic Microangiopathy: A Review of Literature
• Annual trends in atypical haemolytic uremic syndrome management in Japan and factors influencing early diagnosis and treatment: a retrospective study
• Anti-C5 monoclonal antibody treatment showing pathological resolution of complement-mediated atypical hemolytic uremic syndrome: a case report
• Anti-factor H Autoantibody-Associated Hemolytic Uremic Syndrome: A Rare Entity in a Pediatric Patient
• Application of eculizumab, a terminal complement inhibitor, in the management of atypical hemolytic uremic syndrome in a 14-month-old Chinese pediatric patient: a case report
• Atypical haemolytic uremic syndrome in a patient with severe Babesiosis
• Atypical hemolytic uremic syndrome during induction chemotherapy in neuroblastoma, a rare phenomenon or common congenital predisposition?
• Atypical hemolytic-uremic syndrome after COVID-19 vaccine: A case report
• Breastfeeding and hemolytic uremic syndrome
• Bronchopleural fistula management in a pediatric patient requiring extracorporeal membrane oxygenation
• Case presentation: a severe case of cobalamin c deficiency presenting with nephrotic syndrome, malignant hypertension and hemolytic anemia
• Case Report: C3 deficiency in two siblings
• Characterization of Shiga Toxin-producing Escherichia coli Isolated from Cattle Around Ulaanbaatar City, Mongolia
• Clinical characteristics and genetic profile of complement system in renal thrombotic microangiopathy in patients with severe forms of arterial hypertension
• Clinical efficacy and safety of switching from eculizumab to ravulizumab in adult patients with aHUS- real-world data
• Clinical presentation and management of atypical hemolytic uremic syndrome in Latin America: a narrative review of the literature
• Coagulation and complement crosstalk: molecular mechanisms of complement-mediated diseases
• Complement Biosensors Identify a Classical Pathway Stimulus in Complement-Mediated Hemolytic Uremic Syndrome
• Comprehensive functional characterization of complement factor I rare variant genotypes identified in the SCOPE geographic atrophy cohort
• Correction to: Adolescence-onset atypical hemolytic uremic syndrome: is it different from infant-onset?
• Crovalimab: First Approval
• Deletion of Sphingosine Kinase 2 Attenuates Acute Kidney Injury in Mice with Hemolytic-Uremic Syndrome
• Determinants of Sporadic Shiga Toxin-Producing <em>Escherichia coli</em> (STEC) Infection in Denmark, 2018-2020: A Matched Case-Control Study
• Differential Colonization and Mucus Ultrastructure Visualization in Bovine Ileal and Rectal Organoid-Derived Monolayers Exposed to Enterohemorrhagic <em>Escherichia coli</em>
• Diversity of Shiga toxin transducing phages in <em>Escherichia coli</em> O145:H28 and the different Shiga toxin 2 production levels associated with short- or long-tailed phages
• Do asymptomatic STEC-long-term carriers need to be isolated or decolonized? New evidence from a community case study and concepts in favor of an individualized strategy
• Eculizumab for adult patients with atypical haemolytic-uraemic syndrome: full dataset analysis of Japanese post-marketing surveillance
• Eculizumab for Shiga-toxin-induced hemolytic uremic syndrome in adults with neurological involvement
• Efficacy and safety of eculizumab in children with Shiga-toxin-producing Escherichia coli haemolytic uraemic syndrome: the ECUSTEC RCT
• Emerging of Shiga toxin-producing Escherichia coli O177:H11 and O177:H25 from cattle at slaughter in Italy
• Enterohemorrhagic <em>Escherichia coli</em> (EHEC) disrupts intestinal barrier integrity in translational canine stem cell-derived monolayers
• ENTEROHEMORRHAGIC ESCHERICHIA COLI LEADING TO HAEMOLYTIC UREMIC SYNDROME - CASE STUDY AND REVIEW
• Epidemiological Characteristics of Shiga Toxin-Producing <em>Escherichia coli</em> Responsible for Infections in the Polish Pediatric Population
• Evaluation of the Humoral Response after Immunization with a Chimeric Subunit Vaccine against Shiga Toxin-Producing <em>Escherichia coli</em> in Pregnant Sows and Their Offspring
• Evaluation of the results of the patients who underwent plasmapheresis in the pediatric intensive care unit
• Ex vivo C5b-9 Deposition Test to Monitor Complement Activity in Clinical and Subclinical Atypical Hemolytic Uremic Syndrome and in Transplantation-Associated Thrombotic Microangiopathy
• Farm Animal Exposure Setting Impacts Hemolytic Uremic Syndrome Risk Among Cases Infected with Shiga toxin-producing Escherichia coli - Minnesota, 2010-2019
• Farm animal exposure setting impacts hemolytic uremic syndrome risk among Shiga toxin-producing Escherichia coli cases: Minnesota, 2010-2019
• Features of Postpartum Hemorrhage-Associated Thrombotic Microangiopathy and Role of Short-Term Complement Inhibition
• Further Evaluation of Enterohemorrhagic <em>Escherichia coli</em> Gold Nanoparticle Vaccines Utilizing <em>Citrobacter rodentium</em> as the Model Organism
• Genetic and virulence characteristics of hybrid Shiga toxin-producing and atypical enteropathogenic <em>Escherichia coli</em> strains isolated in South Korea
• Genetic Diagnosis of Adult Hemodialysis Patients With Unknown Etiology
• Hemolytic Uremic Syndrome: A COVID-19 Vaccine Reaction Case Report
• How We Interpret Thrombosis with Thrombocytopenia Syndrome?
• Hypertriglyceridemia in STEC-hemolytic uremic syndrome: does it really matter?
• Isolated cerebellar stroke in a paediatric patient with typical haemolytic uraemic syndrome: a case report and literature review
• Kidney involvement in rare hereditary diseases
• Kidney Transplantation in Patients With aHUS: A Comparison of Eculizumab Prophylaxis Versus Rescue Therapy
• Living with Atypical Hemolytic Uremic Syndrome in the Netherlands: Patient and Family Perspective
• Microangiopathic Hemolytic Anemia as a Paraneoplastic Syndrome in a Patient with Metastatic Gastric Cancer
• Mirror Syndrome Combined with Postpartum Hemolytic Uremic Syndrome
• Moss-produced human complement factor H with modified glycans has an extended half-life and improved biological activity
• Mutations in Genes Encoding Subunits of the RNA Exosome as a Potential Novel Cause of Thrombotic Microangiopathy
• O80:H2-Associated Hemolytic Uremic Syndrome without Hemorrhagic Colitis: A Case Report
• One problem, multiple potential targets: Where are we now in the development of small molecule inhibitors against Shiga toxin?
• Outcomes of patients with thrombotic thrombocytopenic purpura treated in an intensive care unit
• Plasma Exchange in Postpartum Hemorrhage (PPH)-Associated Thrombotic Microangiopathy (TMA): A Case Report
• Practical approach to thrombocytopenia in patients with sepsis: a narrative review
• Pregnancy-associated atypical hemolytic uremic syndrome. Case report
• Protein-losing enteropathy as a new phenotype in atypical hemolytic uremic syndrome caused by CD46 gene mutation
• Rapid and Sensitive Detection of Shiga Toxin-Producing <em>Escherichia coli</em> (STEC) from Food Matrices Using the CANARY Biosensor Assay
• Ravulizumab in Atypical Hemolytic Uremic Syndrome: An Analysis of 2-Year Efficacy and Safety Outcomes in 2 Phase 3 Trials
• Recent data on atypical hemolytic uremic syndrome associated with pregnancy, kidney transplantation or hypertensive emergency
• Recurrent complement-mediated Hemolytic uremic syndrome after kidney transplantation
• Selective bacteriophages reduce the emergence of resistant bacteria in bacteriophage-antibiotic combination therapy
• Shiga toxin down-regulates ERG protein in endothelial cells and impairs angiogenesis
• Shiga Toxin-Producing Escherichia coli O157:H7 Illness Outbreak Associated with Untreated, Pressurized, Municipal Irrigation Water - Utah, 2023
• Shiga toxin-producing Escherichia coli O157:H7 outbreak associated with school field trips at a farm animal exhibit-Tennessee, September-October 2023
• Successful 13-year ongoing remission with C5 inhibitor therapy following renal transplant in atypical hemolytic uremic syndrome
• Successful application of eculizumab in typical haemolytic uraemic syndrome
• Successful Management of Atypical Hemolytic-Uremic Syndrome in Pregnancy Using Eculizumab: A Case Review
• Synthetic phage-based approach for sensitive and specific detection of Escherichia coli O157
• The efficacy and safety of eculizumab in patients and the role of C5 polymorphisms
• The role of complement in kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference
• Thrombotic microangiopathy following a white-lipped pit viper envenomation
• Thrombotic Microangiopathy Post-COVID-19 Vaccination
• Transcriptomic and proteomic analysis of the virulence inducing effect of ciprofloxacin on enterohemorrhagic Escherichia coli
• Two cases of typical HUS in adults treated with an anti-C5 monoclonal antibody: a new perspective?
• Vacation in Egypt associated with Shiga toxin-producing <em>Escherichia coli</em> infection in children and adolescents, northern Italy, 2023
• Veno-venous extracorporeal membrane oxygenation in managing acute respiratory distress syndrome associated with hemolytic uremic syndrome and septic shock: a case report
• Virulence genes and pulsed-field gel electrophoresis profiles of Shiga toxin-producing <em>Escherichia coli</em> isolated from different food samples and patients with acute diarrhea
• Weibel-Palade bodies: function and role in thrombotic thrombocytopenic purpura and in diarrhea phase of STEC-hemolytic uremic syndrome
• When a Headache Is Not Just Hypertension: A Case of Atypical Hemolytic Uremic Syndrome in a Young Patient